119 related articles for article (PubMed ID: 1132185)
1. Impaired osteoclastic function and linear bone erosion rate in secondary hyperparathyroidism associated with chronic renal failure.
Jaworski ZF; Lok E; Wellington JL
Clin Orthop Relat Res; 1975; (107):298-310. PubMed ID: 1132185
[TBL] [Abstract][Full Text] [Related]
2. Profiles of cortical remodeling sites in longitudinal rib sections of beagles with renal failure and parathyroid hyperplasia.
Norrdin RW; Shih MS
Metab Bone Dis Relat Res; 1983; 4(6):353-9. PubMed ID: 6664307
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid sonography in secondary hyperparathyroidism: correlation with clinical findings.
Tomić Brzac H; Pavlović D; Halbauer M; Pasini J
Nephrol Dial Transplant; 1989; 4(1):45-50. PubMed ID: 2494598
[TBL] [Abstract][Full Text] [Related]
4. [Parathyroidectomy in secondary hyperparathyroidism in chronic uremic patients under dialysis treatment. Development of the surgical strategy].
Zucchi C
Minerva Med; 1985 Mar; 76(9-10):397-401. PubMed ID: 3982697
[No Abstract] [Full Text] [Related]
5. Skeletal resistance to the calcaemic action of parathyroid hormone in uraemia: a mechanism for the hypocalcaemia and secondary hyperparathyroidism of chronic renal failure.
Massry SG
Clin Endocrinol (Oxf); 1976; 5 Suppl():317S-325S. PubMed ID: 1052781
[No Abstract] [Full Text] [Related]
6. Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats.
Oste L; Behets GJ; Dams G; Bervoets AR; Marynissen RL; Geryl H; Van Hoof VO; De Broe ME; D'Haese PC
Ren Fail; 2007; 29(1):1-12. PubMed ID: 17365904
[TBL] [Abstract][Full Text] [Related]
7. The rate of osteoclastic bone erosion in Haversian remodeling sites of adult dog's rib.
Jaworski ZF; Lok E
Calcif Tissue Res; 1972; 10(2):103-12. PubMed ID: 5083910
[No Abstract] [Full Text] [Related]
8. Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.
Xiao X; Liu Y; Zhong X; Liu Y; Zhou D; Xiong X; Ran J
Nephrology (Carlton); 2019 Jan; 24(1):127-133. PubMed ID: 29278442
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
10. Hyperparathyroidism and experimental chronic renal failure.
Boquist L; Bergdahl L; Andersson L
Urol Res; 1973 May; 1(2):43-9. PubMed ID: 4775661
[No Abstract] [Full Text] [Related]
11. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
Brancaccio D; Galmozzi C; Pizzocaro G
Minerva Med; 1985 Mar; 76(9-10):377-82. PubMed ID: 3982693
[No Abstract] [Full Text] [Related]
12. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
[No Abstract] [Full Text] [Related]
13. Parathyroid morphology in suppressible and nonsuppressible renal hyperparathyroidism.
Black WC; Slatopolsky E; Elkan I; Hoffsten P
Lab Invest; 1970 Nov; 23(5):497-509. PubMed ID: 5483883
[No Abstract] [Full Text] [Related]
14. [A case of secondary hyperparathyroidism; discussion of tertiary hyperparathyroidism].
Huguenin A; Richier JL; Chevrel ML; Ferrand B; Guérin D; Murie N
Ann Endocrinol (Paris); 1971; 32(3):409-29. PubMed ID: 5114906
[No Abstract] [Full Text] [Related]
15. Insufficiency of PTH action on bone in uremia.
Iwasaki Y; Yamato H; Nii-Kono T; Fujieda A; Uchida M; Hosokawa A; Motojima M; Fukagawa M
Kidney Int Suppl; 2006 Jul; (102):S34-6. PubMed ID: 16810309
[TBL] [Abstract][Full Text] [Related]
16. The effect of a diphosphonate on uremic hyperparathyroidism.
Kaye M
Nephron; 1973; 10(2):188-94. PubMed ID: 4710979
[No Abstract] [Full Text] [Related]
17. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
Akmal M; Telfer N; Ansari AN; Massry SG
J Clin Invest; 1985 Oct; 76(4):1695-8. PubMed ID: 4056047
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
19. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
Geng Z; Monier-Faugere MC; Bauss F; Malluche HH
Clin Nephrol; 2000 Jul; 54(1):45-53. PubMed ID: 10939756
[TBL] [Abstract][Full Text] [Related]
20. Secondary hyperparathyroidism in chronic renal failure.
Malmaeus J
Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
